JAIME RODRIGUEZ LOPEZ, MD
Neurology at Pasteur Dr, Palo Alto, CA

License number
California G65342
Category
Neurology
Type
Neurology
Address
Address 2
300 Pasteur Dr, Palo Alto, CA 94305
PO Box 1164, El Granada, CA 94018
Phone
(650) 723-1975
(650) 725-5095 (Fax)
(650) 726-0404

Professional information

Jaime Rodriguez Lopez Photo 1

Jaime Rodriguez Lopez, Stanford CA

Specialties:
Neurologist
Address:
300 Pasteur Dr, Stanford, CA 94305
Education:
University of Washington, School of Medicine - Doctor of Medicine
Stanford Hospital & Clinics - Fellowship - Clinical Neurology
Board certifications:
American Board of Psychiatry and Neurology Certification in Neurology (Psychiatry and Neurology)


Jaime Rodriguez Lopez Photo 2

Jaime Rodriguez Lopez, Stanford CA

Specialties:
Neurology, Obstetrics & Gynecology
Work:
Stanford University
300 Pasteur Dr, Stanford, CA 94305 Stanford Hospital and Clinics
300 Pasteur Dr, Palo Alto, CA 94304
Education:
University of Washington (1987)


Jaime R Lopez Photo 3

Dr. Jaime R Lopez, Stanford CA - MD (Doctor of Medicine)

Specialties:
Neurology, Neuropsychiatry (Neurology)
Address:
300 Pasteur Dr STE A301, Stanford 94305
(650) 723-7093 (Phone)
Certifications:
Neurology, 1995
Awards:
Healthgrades Honor Roll
Languages:
English, Spanish
Hospitals:
300 Pasteur Dr STE A301, Stanford 94305
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
Education:
Medical School
University of Washington
Graduated: 1987
Stanford U Sch Med
Standford U Sch Med


Jaime Lopez Photo 4

Non-Invasive Monitoring Of Intracranial Pressure

US Patent:
2009023, Sep 17, 2009
Filed:
Mar 17, 2008
Appl. No.:
12/049843
Inventors:
Richard A. JAFFE - Palo Alto CA, US
Jaime R. Lopez - El Granada CA, US
Xuefeng Cheng - Cupertino CA, US
Paul Chan - Sunnyvale CA, US
Assignee:
O2 MedTech, Inc. - Los Altos CA
International Classification:
A61B 5/00
US Classification:
600561
Abstract:
Methods, systems, and related computer program products for are described for non-invasive detection of intracranial pressure (ICP) variations in an intracranial compartment of a patient. Optical radiation is propagated transcranially into the intracranial compartment, and optical radiation that has migrated through at least a portion of the intracranial compartment and back out of the cranium is detected. At least one signal representative of the detected optical radiation is processed to extract therefrom at least one component signal that varies in time according to at least one of an intrinsic physiological oscillation and an externally driven oscillation in the patient. Examples of suitable intrinsic physiological oscillations include intrinsic respiratory and cardiac oscillations. Examples of suitable externally driven oscillations include ventilated respiratory oscillations and externally mechanically induced oscillations. The extracted component signal is then processed to generate an output signal representative of the ICP variations in the intracranial compartment.


Jaime Lopez Photo 5

Result Validation In Non-Invasive Cerebral Oxygenation Level Monitoring

US Patent:
2009032, Dec 31, 2009
Filed:
Jun 26, 2008
Appl. No.:
12/146754
Inventors:
Richard A. Jaffe - Palo Alto CA, US
Jaime R. Lopez - El Granada CA, US
Xuefeng Cheng - Cupertino CA, US
International Classification:
A61B 5/1455
US Classification:
600323
Abstract:
Methods, systems, and related computer program products for optically monitoring a chromophore level in a body part of a patient are described. An optical source introduces optical radiation into the body part, and an optical detector receives optical radiation that has propagated through at least a portion of the body part and produces a first signal representative of the received optical radiation. The first signal is processed to produce a chromophore level metric, which is output on a user display, and is further processed to produce a second signal known to exhibit measurably significant timewise fluctuations corresponding to at least one intrinsic physiological oscillation of the patient when the optical source and the optical detector are in proper optical coupling with the body part. An error condition indication is provided if the measurably significant timewise fluctuations are not present in the second signal.


Jaime Lopez Photo 6

Safety Transcutaneous Electrode

US Patent:
2012003, Feb 9, 2012
Filed:
Aug 4, 2011
Appl. No.:
13/198005
Inventors:
Richard A. JAFFE - Stanford CA, US
Jaime R. LOPEZ - El Granada CA, US
Alan Chris ALLISON - Brentwood CA, US
International Classification:
A61B 5/04
US Classification:
600373
Abstract:
Transcutaneous safety electrode assemblies are described that can include a conducting electrode having a sharp end to penetration of the skin of a patient, and a shielding member that is deployable by a user so as to shield the sharp end of the electrode after the electrode is removed from the skin. The shielding member can be deployed by retracting the sharp end of the electrode a protective housing, assisted by spring force provided by the electrode wire so as to self-retract into the protective housing. The deployment and disengagement can be via push button action, and the electrode assembly can be self-retaining on the patient's skin while deployed.